MX2021008602A - Composicion para el tratamiento y/o prevencion de sintomas del tracto urinario inferior. - Google Patents

Composicion para el tratamiento y/o prevencion de sintomas del tracto urinario inferior.

Info

Publication number
MX2021008602A
MX2021008602A MX2021008602A MX2021008602A MX2021008602A MX 2021008602 A MX2021008602 A MX 2021008602A MX 2021008602 A MX2021008602 A MX 2021008602A MX 2021008602 A MX2021008602 A MX 2021008602A MX 2021008602 A MX2021008602 A MX 2021008602A
Authority
MX
Mexico
Prior art keywords
prevention
treatment
urinary tract
lower urinary
tract symptoms
Prior art date
Application number
MX2021008602A
Other languages
English (en)
Inventor
Sossio Morra
Original Assignee
Axeen Pharma S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axeen Pharma S A R L filed Critical Axeen Pharma S A R L
Publication of MX2021008602A publication Critical patent/MX2021008602A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención se refiere a una composición para su uso en el tratamiento y/o prevención de síntomas del tracto urinario inferior (LUTS). La invención se caracteriza porque comprende un extracto de polen que contiene un extracto de polen acuoso obtenido de una mezcla de plantas pertenecientes a las familias Pinaceae y Poaceae, un extracto acuoso de semillas de plantas pertenecientes al género Cucurbita y de vitamina E o sus ésteres para el uso del mismo en el tratamiento y/o prevención de los síntomas del tracto urinario inferior (LUTS) asociados con las fases de llenado, micción y/o post-micción en mujeres.
MX2021008602A 2019-01-18 2020-01-13 Composicion para el tratamiento y/o prevencion de sintomas del tracto urinario inferior. MX2021008602A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1900478A FR3091819B1 (fr) 2019-01-18 2019-01-18 Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
PCT/EP2020/050671 WO2020148224A1 (fr) 2019-01-18 2020-01-13 Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire

Publications (1)

Publication Number Publication Date
MX2021008602A true MX2021008602A (es) 2021-09-21

Family

ID=66867402

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021008602A MX2021008602A (es) 2019-01-18 2020-01-13 Composicion para el tratamiento y/o prevencion de sintomas del tracto urinario inferior.

Country Status (14)

Country Link
US (1) US20230149498A1 (es)
EP (1) EP3911347B1 (es)
JP (1) JP2022522997A (es)
CN (1) CN113316456B (es)
AU (1) AU2020209886A1 (es)
BR (1) BR112021013006A8 (es)
CA (1) CA3123859A1 (es)
DK (1) DK3911347T3 (es)
ES (1) ES2966149T3 (es)
FR (1) FR3091819B1 (es)
MX (1) MX2021008602A (es)
PL (1) PL3911347T3 (es)
PT (1) PT3911347T (es)
WO (1) WO2020148224A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000027423A1 (it) * 2020-11-16 2022-05-16 Kolinpharma S P A Composizione multicomponente e suo uso nel trattamento di patologie della prostata

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3055215B1 (fr) * 2016-08-31 2020-02-14 S.A.M. Serelys Pharma Composition comprenant des extraits de pollen et /ou de pistils
FR3068605B1 (fr) * 2017-07-10 2020-02-21 Serelys Pharma S.A.M. Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
FR3070263B1 (fr) * 2017-08-28 2020-07-24 Serelys Pharma S A M Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite

Also Published As

Publication number Publication date
BR112021013006A8 (pt) 2023-04-11
US20230149498A1 (en) 2023-05-18
CN113316456A (zh) 2021-08-27
PL3911347T3 (pl) 2024-02-05
FR3091819A1 (fr) 2020-07-24
EP3911347B1 (fr) 2023-10-04
ES2966149T3 (es) 2024-04-18
PT3911347T (pt) 2023-12-11
BR112021013006A2 (pt) 2021-09-14
FR3091819B1 (fr) 2021-04-23
WO2020148224A1 (fr) 2020-07-23
AU2020209886A1 (en) 2021-08-26
DK3911347T3 (da) 2023-11-13
CN113316456B (zh) 2024-05-14
CA3123859A1 (fr) 2020-07-23
EP3911347A1 (fr) 2021-11-24
JP2022522997A (ja) 2022-04-21

Similar Documents

Publication Publication Date Title
MX2021000020A (es) Composicion y metodo para tratar el dolor.
MX2019001286A (es) Composicion de cannabis.
MX2019003363A (es) Composiciones farmaceuticas para usarse en la terapia de la blefaritis.
GB0615781D0 (en) Prebiotic composition
WO2007002666A3 (en) Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant
PH12017502325B1 (en) Orodispersible dosage unit containing an estetrol component
MY160409A (en) Compositions for preventing or improving gastrointestinal diseases
WO2018208094A3 (en) A composition comprising a combined herb extract of salvia plebia and red ginseng as active ingredients for preventing or treating a respiratory inflammation and the use thereof
WO2008007227A3 (en) Method and compositions for relieving menopausal and perimenopausal symptoms
MX2016016995A (es) Composiciones de acido fitico, magnesio y polifenoles y su aplicacion para la prevencion de la litiasis renal oxalocalcica.
MX2021000023A (es) Composicion y metodo para el ahorro de opioides.
IN2014MU00327A (es)
MX2011011860A (es) Composicion estimulante inmune que comprende un extracto de aronia sp. en combinacion con selenio y/o zinc.
MX2021008602A (es) Composicion para el tratamiento y/o prevencion de sintomas del tracto urinario inferior.
EP4054335A4 (en) PERIPHERAL-ACTING COMPOSITIONS CONTAINING CANNABIDIOL (CBD) AND USES THEREOF FOR IMPROVING FEMALE SEXUAL FUNCTION OR TREATING FEMALE SEXUAL DISORDERS
MX2020013549A (es) Desarrollo de suplementos alimenticios para la salud y antioxidantes para controlar la hiperuricemia y el estrés oxidativo.
PH12019500137A1 (en) Vaginal composition comprising a combination of estrogen and vitamin d
MX2011011015A (es) Composicion nutricional que comprende un extracto de manzana y que reduce los sintomas de la alergia a los alimentos, en especial, en niños.
MX2017003360A (es) Composicion para la prevencion y/o tratamiento de sintomas de alergia.
MX2021001333A (es) Composiciones y metodos para tratar disfuncion sexual y aumentar la respuesta y placer sexual.
NZ735025A (en) Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males
FR3068605B1 (fr) Composition pour le traitement et/ou la prevention des symptomes du bas appareil urinaire
WO2010143825A3 (en) Anti-arthritic agent using cyathula officinalis
PH12014501823A1 (en) Pharmaceutical composition for treating urinary incontinence and enuresis
MX2021000950A (es) Composiciones que comprenden un extracto de arandano americano y fosfolipidos.